Pegylated interferon

Pegylated interferon (PEG-IFN) is a class of medication that includes three different drugs as of 2012:^[1]

In these formulations, Polyethylene glycol (PEG) is added to make interferon last longer in the body.^[3] They are used to treat both hepatitis B,^[4] hepatitis C^[1] and multiple sclerosis.^[2]

Pegylated interferon is contraindicated in patients with hyperbilirubinaemia.^{[citation needed]}

References[edit]

^ ^a ^b editor, Emilio Jirillo (2008). Hepatitis C virus disease : immunobiology and clinical applications ([Online-Ausg.] ed.). New York: Springer. p. 237. ISBN 978-0-387-71375-5. {{cite book}}: |last= has generic name (help)
^ ^a ^b Kieseier BC, Calabresi PA.; Calabresi (2012). "PEGylation of Interferon-β-1a: A Promising Strategy in Multiple Sclerosis". CNS Drugs. 26 (3): 205–14. doi:10.2165/11596970-000000000-00000. PMID 22201341. S2CID 34290702. Archived from the original on 2013-01-01.
^ Martin P (February 15, 2001). "Hepatology Focus: Update on Hepatitis C Treatment: Pegylated Interferon". medscape.
^ Dancygier H, Allescher HD (2010). Clinical Hepatology. [S.l.]: Springer Berlin Heidelberg. p. 765. ISBN 978-3-642-04509-7.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.